Cellectis Non-GAAP EPS of -$0.16 beats by $0.05, revenue of $33.22M beats by $23.63M

MT HANNACH
1 Min Read
Disclosure: This website may contain affiliate links, which means I may earn a commission if you click on the link and make a purchase. I only recommend products or services that I personally use and believe will add value to my readers. Your support is appreciated!

  • Cell press release (Nasdaq:Clls): Non -gaap EPS of the fourth quarter of – $ 0.16 $ 0.05.
  • Income of $ 33.22 million (+ 1569.3% in Y / Y) beats $ 23.63 million.
  • As of December 31, 2024, Celluctis had $ 264 million in consolidated cash, cash equivalents, limited cash and fixed -term deposits classified as current financial assets. The company estimates that its species, its cash equivalents and its fixed-term deposits will be sufficient to finance its operations in mid-2017.

Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *